Outset Medical Reports Fourth Quarter and Full Year 2025 Financial Results
Outset Medical, Inc. (OM)
Company Research
Source: GlobeNewswire
SAN JOSE, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a first-of-its-kind technology to improve clinical outcomes in dialysis with less cost and complexity, today reported financial results for the fourth quarter and year ended December 31, 2025. Fourth Quarter, Year-End and Recent Highlights Net revenue totaled $28.9 million in the fourth quarter, bringing revenue in 2025 to $119.5 million, a 5% increase over $113.7 million in 2024.Recurring revenue consisting of Tablo consumables and services was $22.5 million in the fourth quarter and grew 6% in 2025 to $88.7 million compared to $83.9 million in 2024.Gross margin expanded by nearly 600 basis points in the fourth quarter to 42.4% (42.9% on a non-GAAP basis). Gross margin for the year of 39.1% (39.6% on a non-GAAP basis) expanded more than 500 basis points from 33.9% in 2024.Year-end cash, including restricted cash, cash equivalents and short-term investments, total
Show less
Read more
Impact Snapshot
Event Time:
OM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
OM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
OM alerts
High impacting Outset Medical, Inc. news events
Weekly update
A roundup of the hottest topics
OM
News
- Outset Medical (NASDAQ:OM) had its price target lowered by analysts at BTIG Research from $17.00 to $15.00. They now have a "buy" rating on the stock.MarketBeat
- Outset Medical, Inc. (OM) Q4 2025 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
- Outset Medical outlines 5%–9% revenue growth for 2026 with next-gen Tablo launch and gross margin expansion [Seeking Alpha]Seeking Alpha
- Outset Medical Q4 Earnings Call Highlights [Yahoo! Finance]Yahoo! Finance
- Stifel Lowers Price Target on Outset Medical, Inc. (OM) to $8, Maintains Buy Rating [Yahoo! Finance]Yahoo! Finance
OM
Earnings
- 2/11/26 - Miss
OM
Sec Filings
- 2/11/26 - Form 8-K
- 2/11/26 - Form SCHEDULE
- 1/27/26 - Form 8-K
- OM's page on the SEC website